benzylsuccinic acid has been researched along with Blood Pressure, High in 1 studies
benzylsuccinic acid: inhibitor of carboxypeptidase A
2-benzylsuccinic acid : A dicarboxylic acid consisting of succinic acid carrying a 2-benzyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Captopril is a remarkably effective new antihypertensive drug designed and developed as a potent and specific inhibitor of angiotensin-converting enzyme, a zinc metallopeptidase that participates in the synthesis of a hypertensive peptide, angiotensin II, and in the degradation of a hypotensive peptide, bradykinin." | 1.26 | Development and design of specific inhibitors of angiotensin-converting enzyme. ( Cheung, HS; Cushman, DW; Ondetti, MA; Sabo, EF, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cushman, DW | 1 |
| Cheung, HS | 1 |
| Sabo, EF | 1 |
| Ondetti, MA | 1 |
1 other study available for benzylsuccinic acid and Blood Pressure, High
| Article | Year |
|---|---|
Development and design of specific inhibitors of angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Humans; Hypertension; | 1982 |